公开(公告)号：US20230210857A1

公开(公告)日：2023-07-06

申请号：US18088137

申请日：2022-12-23

Applicant: Enalare Therapeutics Inc.

Inventor： Joseph V. Pergolizzi ,  Frank Diana ,  Jiayi Chen ,  Devon E. Dodd ,  Isaac Agyemang

IPC: A61K31/53 ,  A61K9/08

CPC classification number: A61K31/53 ,  A61K9/08 ,  A61K9/0019

Abstract: Disclosed in certain embodiments a parenteral formulation comprising a compound of Formula (I) as disclosed herein and a pharmaceutically acceptable excipient, wherein the formulation maintains at least 90% of the compound after accelerated storage conditions of 25° C. at 60% relative humidity for 2 weeks.